SHRENIKA REDDY
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism FESTUS, MO NPI 1801258207
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MO Novo Nordisk AS All categories
General Payments — all program years on this page
$6,630.52
- Category: General Payments
- Program years: PY2021–2024
- Record count: 393
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,455.23 across 88 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,455.23 | 88 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $266.43 | 22 |
| MannKind Corporation | $168.62 | 16 |
| Medtronic, Inc. | $94.91 | 4 |
| Xeris Pharmaceuticals, Inc. | $87.56 | 4 |
| Insulet Corporation | $79.60 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $69.17 | 3 |
| Amgen Inc. | $64.01 | 4 |
| Averitas Pharma Inc. | $63.72 | 3 |
| Lilly USA, LLC | $63.13 | 4 |
| Radius Health, Inc. | $54.36 | 2 |
| Corcept Therapeutics | $51.97 | 3 |
| Amphastar Pharmaceuticals, Inc. | $51.90 | 3 |
| DEXCOM, INC. | $51.55 | 2 |
| Kyowa Kirin, Inc. | $46.53 | 2 |
| Alexion Pharmaceuticals, Inc. | $42.56 | 2 |
| SANOFI-AVENTIS U.S. LLC | $35.91 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.93 | 2 |
| Abbott Laboratories | $24.07 | 1 |
| BETA BIONICS, INC. | $21.35 | 2 |
| Ascendis Pharma Inc | $20.45 | 1 |
| Nevro Corp. | $19.99 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.74 | 1 |
| Antares Pharma, Inc. | $16.90 | 1 |
| Tandem Diabetes Care, Inc. | $15.87 | 1 |
By program year
Records — PY2024 (88)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.